Mona hassanein

Publications
  • Research Article
    Clinical Importance of PRAME Gene Expression in Acute Myeloid Leukemia
    Author(s): Ahmad Baraka, Mona E. Hashem, Shereen ElShorbagy, Mona hassanein and Salah F. ElsayedAhmad Baraka, Mona E. Hashem, Shereen ElShorbagy, Mona hassanein and Salah F. Elsayed

    Background: The PRAME (preferentially expressed antigen of melanoma) gene is frequently over expressed in a wide variety of malignant diseases, including acute myeloid leukemia (AML). Objective: To investigate the expression of PRAME gene in AML and its importance in the prognosis. Patients and methodsThe transcript level of PRAME gene was detected in peripheral blood specimens from 72 de novo AML patients and 40 control subjects by using real-time quantitative PCR and the prognostic value of PRAME was determined through treatment outcome and survival analysis. Results: PRAME gene was highly expressed in 74% of de novo AML cases while low expression was detected among healthy controls, the mean value of PRAME gene expression was highest among M3 AML subtype and lowest among M5b AML subtype. No significant correlation c.. View More»
    DOI: 10.4172/2155-9864.1000373

    Abstract PDF